HAS2 and breast carcinoma: While Sdc-1 depletion was associated with significant subtype-specific expression changes in HA-related factors (HAS2, CD44, RHAMM), our experiments employing the exogenous addition of HA suggest that HA has more of a modulating effect on Sdc-1-dependent processes in breast cancer, which partially acts synergistically.